Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00276237 · ClinicalTrials.gov registry record
Outcomes Following Pulmonary Valve Replacement in Adults
A clinical trial of Heart Disease, Congenital and Pulmonary Valve Replacement, sponsored by Emory University.
- Completed
- Registry status
- 300
- Enrollment target
- 2
- Study locations
NCT00276237: Completed study of Heart Disease, Congenital and Pulmonary Valve Replacement, sponsored by Emory University.
NCT00276237 is a study of Heart Disease, Congenital and Pulmonary Valve Replacement that has completed, run by Emory University. The registered enrollment target is 300 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00276237, a study of Heart Disease, Congenital and Pulmonary Valve Replacement, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
One of the most common residual lesions in adult survivors of pediatric cardiac surgery is pulmonary valve disease, particularly regurgitation. Multiple studies have demonstrated that placement of a pulmonary valve in such patients, results in improved ventricular function and resolution of symptoms. However, the optimal prosthetic valve for use in the pulmonary position has not been defined. There are essentially three alternatives available: the stented bioprosthetic valve, stentless bioprosthetic "tube" grafts used to replace the entire right ventricular outflow tract and mechanical valves. All three of these valve options have been used in adults with congenital heart disease at Emory Healthcare and at Children's Healthcare of Atlanta at Egleston. The goal of this study is to evaluate and compare the indications and short and mid-term outcomes for these alternative therapies.
Conditions Studied
Study Locations (2)
Georgia
- Children's Healthcare of Atlanta - Atlanta
- Emory Healthcare System - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2005-07 |
| Est. Completion | 2005-11 |
What the finished NCT00276237 record still lists
NCT00276237 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Heart Disease, Congenital appearing as the primary indexed condition, and to 0 interventions.
NCT00276237 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT00276237 about?
NCT00276237 is a clinical study titled "Outcomes Following Pulmonary Valve Replacement in Adults". One of the most common residual lesions in adult survivors of pediatric cardiac surgery is pulmonary valve disease, particularly regurgitation. Multiple studies have demonstrated that placement of a pulmonary valve in such patients, results in improved ventricular function and resolution of symptom...
What is the current status of trial NCT00276237?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2005-07. Estimated completion is 2005-11.
What conditions does trial NCT00276237 study?
This clinical trial studies the following conditions: Heart Disease, Congenital, Pulmonary Valve Replacement.
Who is sponsoring clinical trial NCT00276237?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00276237 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Disease, Congenital
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia